Skip to main content

Advertisement

ADVERTISEMENT

Medication Treatments

07/21/2017
New research has found that providing psychosocial counseling and avoiding prescribed opioids or benzodiazepines are among the variables that can reduce mortality rates in opioid use disorders. Medication treatment did not affect death rates.
New research has found that providing psychosocial counseling and avoiding prescribed opioids or benzodiazepines are among the variables that can reduce mortality rates in opioid use disorders. Medication treatment did not affect death rates.
New research has found that...
07/21/2017
Addiction Professional
News
07/17/2017
Researchers have found that individuals with attention-deficit/hyperactivity disorder (ADHD) are at lower risk of alcohol or drug abuse when they are taking ADHD medications.
Researchers have found that individuals with attention-deficit/hyperactivity disorder (ADHD) are at lower risk of alcohol or drug abuse when they are taking ADHD medications.
Researchers have found that...
07/17/2017
Addiction Professional
News
07/14/2017
A new report from the Substance Abuse and Mental Health Services Administration (SAMHSA) shows that the prevalence of non-medical use of prescription opioids in 2012-2014 was highest in Oklahoma and lowest in Minnesota.
A new report from the Substance Abuse and Mental Health Services Administration (SAMHSA) shows that the prevalence of non-medical use of prescription opioids in 2012-2014 was highest in Oklahoma and lowest in Minnesota.
A new report from the Substance...
07/14/2017
Addiction Professional
07/13/2017
An expanded addictions curriculum in Brown University's medical school will allow some young doctors to qualify immediately to prescribe buprenorphine for opioid dependence.
An expanded addictions curriculum in Brown University's medical school will allow some young doctors to qualify immediately to prescribe buprenorphine for opioid dependence.
An expanded addictions...
07/13/2017
Addiction Professional
Blog
06/27/2017
A number of experts in the addiction field would like to see use of the term "medication-assisted treatment" eradicated, saying that it perpetuates stigma.
A number of experts in the addiction field would like to see use of the term "medication-assisted treatment" eradicated, saying that it perpetuates stigma.
A number of experts in the...
06/27/2017
Addiction Professional
06/26/2017
Engaging clients in dialogue during treatment planning and implementation can improve the odds of better outcomes, Robert Matylewicz, DO, FASAM, medical director at Clarity Way Inc., told attendees of the Summit for Clinical Excellence event...
Engaging clients in dialogue during treatment planning and implementation can improve the odds of better outcomes, Robert Matylewicz, DO, FASAM, medical director at Clarity Way Inc., told attendees of the Summit for Clinical Excellence event...
Engaging clients in dialogue...
06/26/2017
Addiction Professional
News
06/21/2017
A Boston Medical Center study has found that just over one-quarter of adolescents and young adults diagnosed with an opioid use disorder from 2001-2014 received a prescription for buprenorphine or naltrexone.
A Boston Medical Center study has found that just over one-quarter of adolescents and young adults diagnosed with an opioid use disorder from 2001-2014 received a prescription for buprenorphine or naltrexone.
A Boston Medical Center study...
06/21/2017
Addiction Professional
News
06/20/2017
Mark Parrino of the American Association for the Treatment of Opioid Dependence (AATOD) will receive the Lisa Mojer-Torres Award next month from Faces & Voices of Recovery.
Mark Parrino of the American Association for the Treatment of Opioid Dependence (AATOD) will receive the Lisa Mojer-Torres Award next month from Faces & Voices of Recovery.
Mark Parrino of the American...
06/20/2017
Addiction Professional
06/20/2017
The National Institute on Drug Abuse (NIDA) is funding a study that will determine whether direct observation of patients receiving buprenorphine treatment can improve retention in treatment and drug use outcomes.
The National Institute on Drug Abuse (NIDA) is funding a study that will determine whether direct observation of patients receiving buprenorphine treatment can improve retention in treatment and drug use outcomes.
The National Institute on Drug...
06/20/2017
Addiction Professional
06/19/2017
The National Institutes of Health (NIH) has announced a partnership with private entities on a three-faceted scientific initiative to address the opioid crisis.
The National Institutes of Health (NIH) has announced a partnership with private entities on a three-faceted scientific initiative to address the opioid crisis.
The National Institutes of...
06/19/2017
Addiction Professional

Advertisement

Advertisement